About WarOnCancer
WarOnCancer is a company based in Stockholm (Sweden) founded in 2015 by Fabian Bolin and Sebastian Hermelin. It operates as a B2C. WarOnCancer has raised $940.41 thousand across 1 funding round from investors including Karl Johan Persson, Stefan Krook and Daniel Pilotti. WarOnCancer operates in a competitive market with competitors including Macmillan Cancer Support, Liangyihui, AccessHope, Peer Medical and OncoveryCare, among others.
- Headquarter Stockholm, Sweden
- Founders Fabian Bolin, Sebastian Hermelin
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$940.41 K (USD)
in 1 rounds
-
Latest Funding Round
$940.41 K (USD), Angel Round
May 06, 2019
-
Investors
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of WarOnCancer
WarOnCancer has successfully raised a total of $940.41K through 1 strategic funding round. The most recent funding activity was a Angel Round of $940.41 thousand completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in WarOnCancer
WarOnCancer has secured backing from 3 investors, including angel investors. Prominent investors backing the company include Karl Johan Persson, Stefan Krook and Daniel Pilotti.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
KJ
Karl Johan Persson |
-
|
Locked | Locked | Locked |
|
SK
Stefan Krook |
Swedish entrepreneur, angel investor, co-founder of Kivra, active in Indian startups
|
Locked | Locked | Locked |
|
DP
Daniel Pilotti |
-
|
Locked | Locked | Locked |
Investor details for WarOnCancer
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by WarOnCancer
Investment portfolio details for WarOnCancer
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - WarOnCancer
Detailed financials for WarOnCancer
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Waroncancer Comparisons
Peer comparison for WarOnCancer
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of WarOnCancer
WarOnCancer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Macmillan Cancer Support, Liangyihui, AccessHope, Peer Medical and OncoveryCare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Online cancer support community
|
|
| Locked | Locked | Locked |
Medical information platform for cancer
|
|
| Locked | Locked | Locked |
Cancer care, support, and expertise are provided for employees.
|
|
| Locked | Locked | Locked |
Online platform providing medical information on cancer
|
|
| Locked | Locked | Locked |
Virtual cancer survivorship clinic services are provided for ongoing support.
|
|
| Locked | Locked | Locked |
Online platform for cancer prevention, treatment, and information is provided.
|
Detailed competitors of WarOnCancer
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Waroncancer
Complete news archive for WarOnCancer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about WarOnCancer
WarOnCancer was founded in 2015 and raised its 1st funding round 4 years after it was founded.
WarOnCancer is headquartered in Stockholm, Sweden.
Fabian Bolin is the current CEO of WarOnCancer. They have also founded this company.
WarOnCancer is a funded company, having raised a total of $940.41K across 1 funding round to date.
WarOnCancer offers an online social platform for cancer patients through providing healthcare solutions, patient services, cancer support, and online platforms. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
WarOnCancer's top competitors include Macmillan Cancer Support, AccessHope and Liangyihui.
WarOnCancer has 3 investors. Key investors include Karl Johan Persson, Stefan Krook, and Daniel Pilotti.